chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of   in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 immunisation.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
This case was reported by a physician via call center representative and described the occurrence of herpes virus infection in a adult patient who received SHINGRIX for prophylaxis. In August 2018, the patient received the 1st dose of SHINGRIX. In August 2018, less than a week after receiving SHINGRIX, the patient experienced herpes virus infection, shingles, malaise, fever, pain and rash. On an unknown date, the outcome of the herpes virus infection, shingles, malaise, fever, pain and rash were unknown. It was unknown if the reporter considered the herpes virus infection, shingles, malaise, fever, pain and rash to be related to SHINGRIX. Additional details reported as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine 1 week ago and presented to me with malaise low grade fever and painful rash right flank clinically suspicious for shingles. The skin biopsy was performed for which results showed Herpesvirus infection. It was advised if ever reported and if possible it was coincidence. The patient also asking if she should get the follow up vaccination in a few months.
Shortly after receiving vaccine, pt was eating with his family and became acutely distended in his abdomen. That night he woke up crying due to abd pain and complaining of shortness of breath but no increased WOB. Was able to pass gas 1.5 days later with relief of distension but then ate bagel for breakfast and distension immediately returned. Seen in our office at that time (2 days post vaccine) with significant abd distension, pain to palpation and coughing with palpation of abd due to extent of distension. Abd XR obtained which  showed dilated loops of small bowel with significant air in the stomach c/w ileus in addition to stool in the rectum. Referred to ER for further evaluation and likely NG fo decompression.
Patient developed soreness and swelling around Right Deltoid muscle with pain on 10/13/06;  erythema developed on 10/15/06.  Patient used Ibuprofen, Tylenol, and an anti-inflammatory cream as treatment.
HEART ATTACK; This spontaneous report received from a consumer via social media via a company representative concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported and expiry: unknown) start therapy date were not reported, dose was not reported, 1 total administered for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the reporter stated that "Or tell that to my sister-in-law who died of a heart attack less than a day of getting the J and J vaccine." On an unspecified date, the patient died from heart attack. It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211242284- JANSSEN COVID-19 VACCINE Ad26.COV2.S- Heart attack. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: HEART ATTACK
within one hour stiff arm and tingling arm - then as night went on, proceeded down elbow to hand (left); did not go away. However she proceeded to get 2nd dose on 11/1/2021. With the 2nd shot, into the same arm, the tingling which did not disappear, intensified. During the two doses, it had progressed into her fingertips. All of her fingers are tingling on the left hand. She does not have a primary MD right now. She is looking for one to establish a relationship with to see if there is any damage or if this is permanent.
Woke up in the morning and my tinnitus was a lot louder than usual.  (I also had that symptom when I had Covid in late October.)  I felt really tired even though I just woke up.  Also tired throughout the day. I was cold all day. Had a fever. I was sore/achy on sides of my body from under my arms to my waist. Sore arm at injection site. I took Tylenol in the early evening and that made me start feeling better.
pt recvd vax; c/o mild n; lightheaded; pale; mild sweating; taken to hosp; IV started;Bp 116/68; released 5pm; c/o cold feeling throughout noc; feeling well on 29nov94;
Multiple itchy small blister on both ankles. Four of five family who all received the Pfizer 2-dose vaccine exprienced same symtptoms;  three males (ages: 56, 28, 21)  and one female (54). The symptoms have not abated as of yet for any of the family members. The symptoms have been ongoing for the female about 8 weeks post-vaccination and the males about 2 weeks post-vaccination.
2 days ago 21Aug2021 she had to stop her walk / she did not feel correct, she did not feel right/she has had unusual effects/; since the vaccine, it is messing with her heart/having heart symptoms right now.; Heart fluttering; Heart palpitations; tightening in the middle of the chest; This spontaneous case was reported by an other health care professional and describes the occurrence of CARDIAC FLUTTER (Heart fluttering), PALPITATIONS (Heart palpitations), CHEST DISCOMFORT (tightening in the middle of the chest), FEELING ABNORMAL (2 days ago 21Aug2021 she had to stop her walk / she did not feel correct, she did not feel right/she has had unusual effects/) and CARDIAC DISORDER (since the vaccine, it is messing with her heart/having heart symptoms right now) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021, the patient experienced CARDIAC FLUTTER (Heart fluttering) (seriousness criteria medically significant and life threatening), PALPITATIONS (Heart palpitations) (seriousness criteria medically significant and life threatening), CHEST DISCOMFORT (tightening in the middle of the chest) (seriousness criteria medically significant and life threatening) and CARDIAC DISORDER (since the vaccine, it is messing with her heart/having heart symptoms right now.) (seriousness criterion life threatening). On 21-Aug-2021, the patient experienced FEELING ABNORMAL (2 days ago 21Aug2021 she had to stop her walk / she did not feel correct, she did not feel right/she has had unusual effects/) (seriousness criteria medically significant and life threatening). At the time of the report, CARDIAC FLUTTER (Heart fluttering), PALPITATIONS (Heart palpitations), CHEST DISCOMFORT (tightening in the middle of the chest), FEELING ABNORMAL (2 days ago 21Aug2021 she had to stop her walk / she did not feel correct, she did not feel right/she has had unusual effects/) and CARDIAC DISORDER (since the vaccine, it is messing with her heart/having heart symptoms right now.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Aug-2021, Blood pressure measurement (70-90-120): 150/90 (High) patient  BP was 150/90 (baseline usually 120/70-90).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter.  Treatment medication not reported.  Company comment: Very limited information regarding this event/s has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time. Further information has been requested.
Refrigerator was left open / temperature / over 46 F since 10:30pm / to 10am; This case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Boostrix, Engerix B and Shingrix. On an unknown date, unknown after receiving Boostrix, Engerix B and Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not reported. On 26th March 2021, the refrigerator was left open and so the temperature was over 46 degree fahrenheit since 10:30pm all the way upto 10am on 27th March 2021, which led to incorrect storage of drug. The reporter wanted to know if the vaccines were still viable or not. The reporter consented to follow up.
NEXT DAY:  woke up very sore, body aches, like tons of brick on me, headache, cold (needed a thick sweater and I am in specific area where it is a warm fall); also pain in both armpits (not sure if that's related, but I  have not had that pain before). couldn't get up so stayed in bed. Doctor husband gave me ibuprofen. Around 430pm - managed to will myself to get dress and go to church. Then at dinner forced myself to eat (no appetite).  2am woke up very itchy and noticed red rash on right torso just below right breast.  applied Triamcinolone cream.  DAY 2 - body aches less but headaches persisted and felt extremely tired. noticed rash on the left arm just below the injection site. several patches. itchy but not as itchy as the one on the torso.  DAY3 - drove mom to Dentist appt at 2pm. When I got back home at 6 - I was exhausted! and went to bed at 9 (I usually go to bed at midnight or a bit after).  I keep waking up at night with this severe itch. it's like having throbbing pain except it's throbbing itchiness. put warm towel on then dried then more triamcinolone. every few hours DAY 4 - just a small headache BUT STILL VERY ITCHY.  Triamcinolone doesnt seem to help. Then applied Desoximethasone 0.25% (Rx from last year's ezcema flare). that helped but still itchy. been applying it all day and it's less itchy as I write this report. I have photos too.
Neck pain, headache and sensitivity when moving head. Symptoms happened within 3-4 hours of vaccine.
Primary vaccinee who developed on day 8 red bumps on his forearms and then legs. Bumps were pruritic. He was evaluated on day 15 and lesions were noted on ears, neck, palms, forearms, dorsal hands, shins and dorsal feet. Had chest achiness and pressure 7 days ago that was intermittent until 4 days ago. Now pain is resolved. Chest pain start: 03/23/2007 End: 03/26/2007 Symptom: Rash, diffuse Start: 03/23/2007 Comment: pruritic, deep vesicles on erythematous papular base.
Person got dose 1, Dose 2 is 4 days overdue; Case reference number US-BN-2021-002098 is a spontaneous case report initially received on 15-Jul-2021 from other health care professional via Agency (reference number: USBAV21-0361) and concerns a female patient of unknown age.  The patient's medical history and concomitant medication details were not provided.  On 08-Jul-2021, the patient was vaccinated with first dose of RabaVert (Inactivated Rabies Virus Vaccine, batch number: not provided) at unknown dose, administered intramuscularly, for post-exposure prophylaxis.   On an unspecified date in Jul-2021, the patient was supposed to receive a second dose, but it was four days overdue (explicitly coded as 'Inappropriate schedule of vaccine administered').  At the time of this report, it was unknown whether the patient developed any adverse event.  The reporter assessed the case as non-serious and not related to RabaVaert.  No further information was provided.; Reporter's Comments: Inappropriate schedule of product administration is listed by convention. Reportedly, the patient received the 2nd dose of Rabavert that was four days overdue, which was considered inappropriate schedule of product administration. No adverse events were reported. Inappropriate schedule of product administration is not related to Rabvert, but due to human action.; Sender's Comments: Inappropriate schedule of product administration is listed by convention. Reportedly, the patient received the 2nd dose of Rabavert with  four days overdue, which was considered inappropriate schedule of product administration. No adverse events were reported. Inappropriate schedule of product administration is not related to Rabvert, but due to human action.
Uses a walker / Can't walk today; Legs / extremely painful.; Back / extremely painful.; Bad headache; Could hardly get up; Her legs wouldn't hold her / Legs and back are weak; This case was reported by a consumer via call center representative and described the occurrence of headache in a 90-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received in September 2020).   On 30th November 2020, the patient received the 2nd dose of Shingrix. On 30th November 2020, less than a day after receiving Shingrix, the patient experienced headache, mobility decreased and muscle weakness. On 1st December 2020, the patient experienced unable to walk, leg pain and back pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the headache was not recovered/not resolved and the outcome of the mobility decreased, muscle weakness, unable to walk, leg pain and back pain were unknown.   It was unknown if the reporter considered the headache, mobility decreased, muscle weakness, unable to walk, leg pain and back pain to be related to Shingrix.  Additional details were provided as follows: The patient had no problems after her first Shingrix shot. The patient had her second Shingrix shot in right arm a day before reporting and that night she got up to get Tylenol for a bad headache and she could hardly get up, her legs would not hold her. The patient used a walker and she can not walk on the day of reporting, her legs and back were weak and extremely painful. The reporter consented to follow up.
I got the 1st and 3nd shot and still got them/ Suspected vaccination failure; I got the 1st and 3nd shot and still got them; It was 3 months and still painful; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient reported case for herself/himself. The age at vaccination was not reported. The patient got the 1st and 2nd shot and still got shingles, it was 3 months and was painful till the time of reporting. The patient stated because shingle shot was received did not mean that he/she would not get shingles, they just would not be as bad. This case was considered to be a suspected vaccination failure case, as the details regarding being full vaccination schedule, laboratory confirmation for shingles and exact time to onset were unknown.
The pt developed chicken pox rash and discomfort. No fever. Treated with Benadryl and Aveeno baths.
Fever ranging from 101-103 from Friday-Tuesday.  Not sleeping. Crying and inconsolable at times. Brought to doctors on Tuesday and amoxicillin prescribed and remedied
Blood pressure jumped very high 191/95 evening a few hours after injection  Called fam Dr.  Advised to do another 100 mg metoprolol  Pressure still high in morning.  Cardiologist added morning dose 50 mg metoprolol Not working   Given clonodine to take for emergency because still seeing nighttime  systolic over 180 snd diastolic at 103.  On day 13  post injection bp still 189/105. Amlodipine added.  Three doses of clonidine used so far.
She reported to the nurse at the convent that she had "flu-like" symptoms x1 week that started the day after receiving immunizations & her right arm was swollen & sore from the shoulder down past her elbow - also reddened in color - left arm fine.
no additional AE reported; she was unsure if any of these vaccines had been administered since the excursion occurred; This spontaneous report has been received from a medical assistant, concerning a 2-years-old male of patient. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided.   On 22-AUG-2022, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (strength, dose, frequency, vaccination scheme, route of administration, and anatomical location were not provided) (lot number W002894 has been verified to be valid; expiration date reported and established as 06-MAR-2023). The administered dose of the vaccine was stored at a temperature of 52.2 degrees Fahrenheit (F), during a time frame of 2 hours and 53 minutes, and at a temperature of 33.6 F, during a time frame of 4 hours and 59 minutes. There was no previous temperature excursion reported. There was no adverse effect reported. ; Sender's Comments:  US-009507513-2210USA004932:MSD US-009507513-2210USA009380:MSD US-009507513-2210USA009377:MSD US-009507513-2210USA009379:MSD
Pt recvd 1 dose Hep B vax on 8NOV89, & 2 doses 11DEC89, & 4MAY90 & was bound to be a non-responder;
Severe fatigue and muscle/joint aches and nausea for 36 hours; unable to do any regular daily activities. This was Shingrix dose #2; had a similar adverse reaction to dose #1.
ED to Hosp-Admission Discharged  2/23/2021 - 2/25/2021 (2 days) Treatment team Costochondritis Principal problem Discharge Summary (Physician Assistant) ? ? Internal Medicine Cosigned by: MD at 2/27/2021  4:06 PM           Discharge Summary   Hospitalist Medicine        Admission Date: 2/23/2021 Length of Stay: 0 Days Discharge Date: 2/25/2021     Admission Diagnosis     Hospital Problems          POA   * (Principal) Costochondritis Yes       COVID-19 Yes         Problem List          Resolved POA            Resolved Problems   Atypical chest pain 2/25/2021 Yes   SIRS (systemic inflammatory response syndrome) (CMS/HCC) 2/25/2021 Yes   Hyponatremia 2/25/2021 Yes   Dehydration 2/25/2021 Yes       Home Or Self Care   CODE STATUS: Full Code     Active Issues Requiring Follow-up           Test Results Pending at Discharge     Pending Labs    Order Current Status   Blood culture x 2 SETS Preliminary result   Blood culture x 2 SETS Preliminary result         Hospital Course         Hospital Course:   Please refer to the admitting providers H&P for full history. Patient is a 51-year-old male with a PMHx significant for hemochromatosis, sarcoidosis and morbid obesity who initially presented to the ED for evaluation of chest pain, cough and shortness of breath.   On presentation, vitals were mostly unremarkable other than some mild tachycardia and tachypnea.  Patient was able to maintain adequate oxygenation on room air but was placed on supplemental oxygen for comfort.  Blood work was mostly unremarkable.  ABG was not particularly concerning.  Troponin was negative x3.  Patient underwent chest CTA which showed basilar atelectasis bilaterally and scattered groundglass opacities and scattered borderline size hilar and mediastinal lymph nodes consistent with patient's known sarcoidosis.   Patient was treated with supportive care and monitored overnight.  He was able to maintain sufficient oxygen levels.  On the time my evaluation, patient continues to complain of bilateral rib pain worse with deep breaths consistent with costochondritis.  I discussed with the patient that he will need to continue to take NSAIDs on a scheduled basis to help with his discomfort.  Additionally I offered to prescribe cough medicine. I discussed possibly discharging the patient on steroids however he states that he makes a point to avoid taking steroids due to his history of hemochromatosis.  At this point, patient no longer requires care in the hospital and can be discharged home.  Patient is agreeable with the plan and all questions have been answered appropriately.
Plaque psoriasis spots on left knee, above upper left thigh, left elbow and on tailbone; This spontaneous case was reported by a consumer and describes the occurrence of PSORIASIS (Plaque psoriasis spots on left knee, above upper left thigh, left elbow and on tailbone) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PSORIASIS (Plaque psoriasis spots on left knee, above upper left thigh, left elbow and on tailbone). At the time of the report, PSORIASIS (Plaque psoriasis spots on left knee, above upper left thigh, left elbow and on tailbone) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment information mentioned.  Patient experienced possible lack of effect towards suspect Humira and got plaque psoriasis spots on left knee, above upper left thigh, left elbow and on tail bone.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
That evening I began to have a fever and chills.  I took tylenol to try to help reduce the fever, which it did not help.  during the middle of the night I was woke up with an urge to vomit.  I ended up vomiting multiple times throughout the day and had a debilitating migraine.  after 26 hours since the shot was given I would finally be able to function as the migraine started to subside as well as the nausea.  My arm was also quite sore for about 4 days after the shot.
The patient presented to medical center with stroke like symptoms on 4/8/21, the day following his  J&J COVID vaccine at the medical center. He was recently admitted to medical center for stroke like symptoms and bilateral leg pain that has reappeared.  Both times the patient presented to the hospital, he was given TPA and symptoms subsequently resolved, however we continue to have no clear findings on imaging  regarding strokes. Patient continues to complain of fatigue that is unresolvable.  He and his wife strongly feel it should be reported regarding possible side effects and to go on the CDC clinical evaluation for possible adverse reaction to the Vaccine.